{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:06:33Z","timestamp":1772136393365,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL155378"],"award-info":[{"award-number":["R01HL155378"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS121234"],"award-info":[{"award-number":["R01 NS121234"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-01321-7","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:15:42Z","timestamp":1748996142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of ventricular arrhythmias with lamotrigine: an observational cohort study"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0124-0404","authenticated-orcid":false,"given":"Sodam","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Landon","family":"Welch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertha","family":"De Los Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0750-2308","authenticated-orcid":false,"given":"Przemys\u0142aw B.","family":"Radwa\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9543-1898","authenticated-orcid":false,"given":"Mark A.","family":"Munger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8676-7434","authenticated-orcid":false,"given":"Kibum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"1321_CR1","unstructured":"Kane, S. P. Lamotrigine - Drug usage statistics. Accessed 06\/13\/2024 https:\/\/clincalc.com\/DrugStats\/Drugs\/Lamotrigine"},{"key":"1321_CR2","doi-asserted-by":"publisher","unstructured":"Nolan, S. J., Tudur Smith, C., Weston, J. & Marson, A. G. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev. ;11(11):CD001031. doi: 10.1002\/14651858.CD001031.pub3. Update in: Cochrane Database Syst Rev. 2018;6:CD001031. (2016). https:\/\/doi.org\/10.1002\/14651858.CD001031.pub4. Database Syst Rev. 2016;11(11):Cd001031. 10.1002\/14651858.CD001031.pub3.","DOI":"10.1002\/14651858.CD001031.pub4"},{"issue":"4","key":"1321_CR3","first-page":"463","volume":"3","author":"F Ng","year":"2007","unstructured":"Ng, F., Hallam, K., Lucas, N. & Berk, M. The role of lamotrigine in the management of bipolar disorder. Neuropsychiatr Dis. Treat. 3 (4), 463\u2013474 (2007).","journal-title":"Neuropsychiatr Dis. Treat."},{"issue":"7","key":"1321_CR4","doi-asserted-by":"publisher","first-page":"6050","DOI":"10.3390\/ijms24076050","volume":"24","author":"B Costa","year":"2023","unstructured":"Costa, B. & Vale, N. Understanding Lamotrigine\u2019s role in the CNS and possible future evolution. Int. J. Mol. Sci. 24 (7), 6050. https:\/\/doi.org\/10.3390\/ijms24076050 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1321_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/BF00373920","volume":"430","author":"X Xie","year":"1995","unstructured":"Xie, X., Lancaster, B., Peakman, T. & Garthwaite, J. Interaction of the antiepileptic drug lamotrigine with Recombinant rat brain type IIA Na\u2009+\u2009channels and with Na\u2009+\u2009channels in rat hippocampal neurones. Pfluegers Arch. Eur. J. Physiol. 430, 437\u2013446 (1995).","journal-title":"Pfluegers Arch. Eur. J. Physiol."},{"issue":"6","key":"1321_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/sj.bjp.0701221","volume":"121","author":"CC Kuo","year":"1997","unstructured":"Kuo, C. C. & Lu, L. Characterization of lamotrigine Inhibition of Na\u2009+\u2009channels in rat hippocampal neurones. Br. J. Pharmacol. 121 (6), 1231\u20131238. https:\/\/doi.org\/10.1038\/sj.bjp.0701221 (1997).","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"1321_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1017\/s1481803500014093","volume":"8","author":"TJ Herold","year":"2006","unstructured":"Herold, T. J. Lamotrigine as a possible cause of QRS prolongation in a patient with known seizure disorder. CJEM 8 (5), 361\u2013364. https:\/\/doi.org\/10.1017\/s1481803500014093 (2006).","journal-title":"CJEM"},{"issue":"4","key":"1321_CR8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12012-014-9300-0","volume":"15","author":"P Chavez","year":"2015","unstructured":"Chavez, P., Casso Dominguez, A. & Herzog, E. Evolving electrocardiographic changes in lamotrigine overdose: A case report and literature review. Cardiovasc. Toxicol. 15 (4), 394\u2013398. https:\/\/doi.org\/10.1007\/s12012-014-9300-0 (2015).","journal-title":"Cardiovasc. Toxicol."},{"issue":"7","key":"1321_CR9","doi-asserted-by":"publisher","first-page":"1324e","DOI":"10.1016\/j.ajem.2018.04.008","volume":"36","author":"A Dream","year":"2018","unstructured":"Dream, A., Holmgren, H., Merrill, R. & Simon, E. L. Refractory ventricular fibrillation in patient taking lamictal. Am. J. Emerg. Med. 36 (7), 1324e. 1-1324.e2 (2018). Epub 2018 Apr 5.","journal-title":"Am. J. Emerg. Med."},{"key":"1321_CR10","doi-asserted-by":"publisher","first-page":"1005952","DOI":"10.3389\/fcvm.2022.1005952","volume":"9","author":"H Omer","year":"2022","unstructured":"Omer, H. et al. Unmasking of Brugada syndrome by lamotrigine in a patient with pre-existing epilepsy: A case report with review of the literature. Front. Cardiovasc. Med. 9, 1005952. https:\/\/doi.org\/10.3389\/fcvm.2022.1005952 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"1321_CR11","doi-asserted-by":"crossref","unstructured":"Contreras Vite, J. A., Vega Valle, C., Biekeu Mbem, H., Boivin, S-M. & Dumaine, R. Epilepsy-Induced high affinity blockade of the cardiac sodium current INa by lamotrigine; A potential for acquired arrythmias. Pharmaceuticals. 15(10)1208. INa by lamotrigine; A potential for acquired arrhythmias. Pharmaceuticals 2022;15:1208. (2022).","DOI":"10.3390\/ph15101208"},{"key":"1321_CR12","unstructured":"Xiaolei Meng, D. R. K. & Przemyslaw Radwanski LTG Promotes Heterogenous Cardiac Conduction Slowing and Reentrant Ventricular Tachycardia. American Epilepsy Society (2023). https:\/\/aesnet.org\/abstractslisting\/transcriptome-wide-survey-via-rna-seq-identifies-alterations-in-splicesosome-gene-expression-in-lymphoblast-cell-lines-from-dravet-syndrome-patients Accessed 02\/20\/2024."},{"issue":"3","key":"1321_CR13","doi-asserted-by":"publisher","first-page":"153575972199634","DOI":"10.1177\/1535759721996344","volume":"21","author":"JA French","year":"2021","unstructured":"French, J. A. et al. FDA safety warning on the cardiac effects of LTG: an advisory from the ad hoc ILAE\/AES task force. Epilepsy Curr. 21 (3), 1535759721996344. https:\/\/doi.org\/10.1177\/1535759721996344 (2021).","journal-title":"Epilepsy Curr."},{"issue":"9","key":"1321_CR14","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1111\/epi.17696","volume":"64","author":"M Aboukaoud","year":"2023","unstructured":"Aboukaoud, M., Wilf-Yarkoni, A. & Maor, E. Investigation of cardiac arrhythmia events in patients treated with lamotrigine: FDA adverse event reporing system analysis. Epilepsia 64 (9), 2322\u20132329. https:\/\/doi.org\/10.1111\/epi.17696 (2023). Epub 2023 Jul 2.","journal-title":"Epilepsia"},{"key":"1321_CR15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/epi.17339","volume":"63","author":"J Chistensen","year":"2022","unstructured":"Chistensen, J., Trabjerg, B. B. & Dreier, J. W. Cardiac morbidity and mortality associated with the use of lamotrigine. Epilepsia 63, 1271\u20131280. https:\/\/doi.org\/10.1111\/epi.17339 (2022).","journal-title":"Epilepsia"},{"key":"1321_CR16","unstructured":"Glasheen, W. P. et al. Charlson Comorbidity Index: ICD-9 Update and ICD-10 Translation. Am. Health Drug Benefits. 12 (4) 188\u2013197. (2019)."},{"issue":"11","key":"1321_CR17","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan, H. et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med. Care. 43 (11), 1130\u20131139. https:\/\/doi.org\/10.1097\/01.mlr.0000182534.19832.83 (2005).","journal-title":"Med. Care"},{"key":"1321_CR18","doi-asserted-by":"publisher","unstructured":"Husein, N., Thijs, R. D., Bunschoten, J. W., Keezer, M. R. & Sander, J. W. Concerns about lamotrigine. Lancet Neurol. 20 (6) 418\u2013419. https:\/\/doi.org\/10.1016\/S1474-4422(21)00132-0. PMID: 34022162.  (2021).","DOI":"10.1016\/S1474-4422(21)00132-0"},{"key":"1321_CR19","unstructured":"Bipolar Disorder. National Insitute of Menal Health. https:\/\/www.nimh.nih.gov\/health\/statistics\/bipolar-disorder Accessed 06\/13\/2024."},{"key":"1321_CR20","doi-asserted-by":"publisher","first-page":"120644","DOI":"10.1016\/j.jns.2023.120644","volume":"448","author":"L Orts","year":"2023","unstructured":"Orts, L., Flumian, C. & Montastruc, F. Lamotrigine and risk of arrhythmias: A global pharmacovigilance analysis. J. Neurol. Sci. 448, 120644. https:\/\/doi.org\/10.1016\/j.jns.2023.120644 (2023).","journal-title":"J. Neurol. Sci."},{"key":"1321_CR21","unstructured":"Lamotrigine Prescribine Information. GlaxoSMithKline. Research Triangle Park. 10\/12\/2020."},{"key":"1321_CR22","doi-asserted-by":"publisher","unstructured":"Ingleby-Talecki, L. et al. Cardiac sodium channel inhibition by lamotrigine: in vitro characterization and clinical implications. Clin. Transl Sci. 2022 15 (8) 1978\u20131989. https:\/\/doi.org\/10.1111\/cts.13311. Epub 2022.","DOI":"10.1111\/cts.13311"},{"issue":"3","key":"1321_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s00380-020-01716-8","volume":"36","author":"A Goto","year":"2021","unstructured":"Goto, A. et al. Reverse translational analysis of clinically reported, lamotrigine-induced cardiovascular adverse events using the halothane-anesthetized dogs. Heart Vessels. 36 (3), 424\u2013429. https:\/\/doi.org\/10.1007\/s00380-020-01716-8 (2021). Epub 2020.","journal-title":"Heart Vessels"},{"issue":"2","key":"1321_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/biomedicines11020477","volume":"11","author":"L Jia","year":"2023","unstructured":"Jia, L., Verkerk, A. O. & Tan, H. L. The Anti-Epileptic drugs lamotrigine and valproic acid reduce the cardiac sodium current. Biomedicines 11 (2), 477. https:\/\/doi.org\/10.3390\/biomedicines11020477 (2023).","journal-title":"Biomedicines"},{"issue":"2","key":"1321_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11920-020-1130-0","volume":"22","author":"JN Miller","year":"2020","unstructured":"Miller, J. N. & Black, D. W. Bipolar disorder and suicide: a review. Curr. Psychiatry Rep. 22 (2), 6. https:\/\/doi.org\/10.1007\/s11920-020-1130-0 (2020).","journal-title":"Curr. Psychiatry Rep."},{"issue":"3","key":"1321_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-2125.2008.03250.x","volume":"66","author":"R Dixon","year":"2008","unstructured":"Dixon, R. et al. LTG does not prolong QTc Ina thorough QT\/QTc study in health subjects. Brit J. Clin. Pharmacol. 66 (3), 396\u2013404. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03250.x (2008).","journal-title":"Brit J. Clin. Pharmacol."},{"key":"1321_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.genhosppsych.2022.06.004","volume":"78","author":"JA Restrepo","year":"2022","unstructured":"Restrepo, J. A. et al. The assessment of cardiac risk in patients taking lamotrigine; a systematic review. Gen. Hosp. Psychiatry. 78, 14\u201327 (2022). Epub 2022 Jun 22.","journal-title":"Gen. Hosp. Psychiatry"},{"key":"1321_CR28","doi-asserted-by":"publisher","unstructured":"Macdonald, R. L. & Kelly, K. M. Antiepileptic drug mechanisms of action. Epilepsia. 36 2 S2-12. (1995). https:\/\/doi.org\/10.1111\/j.1528-1157. 1995.","DOI":"10.1111\/j.1528-1157"},{"key":"1321_CR29","doi-asserted-by":"publisher","unstructured":"Radwa\u0144ski, P. B., Greer-Short, A. & Poelzing, S. Inhibition of Na\u2009+\u2009channels ameliorates arrhythmias in a drug-induced model of Andersen-Tawil syndrome. Heart Rhythm.   10 (2) 255\u2009\u2013\u200963 https:\/\/doi.org\/10.1016\/j.hrthm.2012.10.005. Epub. PMID: 23041575. 2012.","DOI":"10.1016\/j.hrthm.2012.10.005"},{"issue":"10","key":"1321_CR30","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00018-005-5571-8","volume":"63","author":"V Cruciani","year":"2006","unstructured":"Cruciani, V. & Mikalsen, S. O. The vertebrate connexin family. Cell. Mol. Life Sci. 63 (10), 1125\u20131140. https:\/\/doi.org\/10.1007\/s00018-005-5571-8 (2006).","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"1321_CR31","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.cardiores.2003.12.007","volume":"62","author":"NJ Severs","year":"2004","unstructured":"Severs, N. J. et al. Gap junction alterations in human cardiac disease. Cardiovasc. Res. 62(2), 368\u2013377. https:\/\/doi.org\/10.1016\/j.cardiores.2003.12.007 (2004).","journal-title":"Cardiovasc. Res."},{"key":"1321_CR32","doi-asserted-by":"publisher","unstructured":"Burnham, M. P. et al. Investigation of connexin 43 uncoupling and prolongation of the cardiac QRS complex in preclinical and marketed drugs. Br J Pharmacol.  171(21) 4808-19. (2014). https:\/\/doi.org\/10.1111\/bph.12554. 2014.","DOI":"10.1111\/bph.12554"},{"key":"1321_CR33","doi-asserted-by":"publisher","unstructured":"Veeraraghavan, R. et al. Sodium channels in the Cx43 gap junction perinexus may constitute a cardiac ephapse: an experimental and modeling study. Pflugers Arch. ;467(10):2093\u2009\u2013\u2009105. (2015). https:\/\/doi.org\/10.1007\/s00424-014-1675-z. Epub 2015. atrioventricular junction and atrioventricular node in the rat. Circulation. 2006;114(13):1360-71. doi: 10.1161\/CIRCULATIONAHA.106.613182. Epub 2006.","DOI":"10.1007\/s00424-014-1675-z"},{"issue":"17","key":"1321_CR34","first-page":"e1748","volume":"26 98","author":"JW Bunschoten","year":"2022","unstructured":"Bunschoten, J. W. et al. Sudden death and cardiac arrythmia with lamotrigine: A rapid systematic review. Neurology 26 98 (17), e1748\u2013e1760 (2022).","journal-title":"Neurology"},{"issue":"9","key":"1321_CR35","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1111\/epi.17339","volume":"63","author":"J Christensen","year":"2022","unstructured":"Christensen, J., Trabjerg, B. B. & Dreier, J. W. Cardiac morbidity and mortality are associated with the use of lamotrigine. Epilepsia 63 (9), 2371\u20132380 (2022).","journal-title":"Epilepsia"},{"issue":"2","key":"1321_CR36","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/epi4.12693","volume":"8","author":"R Nightscales","year":"2023","unstructured":"Nightscales, R. et al. Risk of sudden unexpected death in epilepsy (SUDEP) with lamotrigine and other sodium channel-modulating Antiseizure medications. Epilepsia Open. 8 (2), 334\u2013345 (2023).","journal-title":"Epilepsia Open."},{"key":"1321_CR37","doi-asserted-by":"publisher","first-page":"109496","DOI":"10.1016\/j.yebeh.2023.109496","volume":"149","author":"A Biehl","year":"2023","unstructured":"Biehl, A. et al. Lamotrigine use and potential for adverse cardiac effects: A retrospective evaluation in a veteran population. Epilepsy Behav. EB. 149, 109496 (2023).","journal-title":"Epilepsy Behav. EB"},{"issue":"2","key":"1321_CR38","doi-asserted-by":"publisher","first-page":"e004662","DOI":"10.1161\/CIRCEP.116.004662","volume":"10","author":"S Sirichand","year":"2017","unstructured":"Sirichand, S. et al. Incidence of idiopathic ventricular arrhythmias: A population-based study. Circ. Arrhythm. Electrophysiol. 10 (2), e004662 (2017).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"1321_CR39","doi-asserted-by":"crossref","unstructured":"Kim, S. et al. Association of ventricular arrhythmias with lamotrigine: an observational cohort study. MedRxiv Prepr Serv. Health Sci. 2024 2024.09.10.24313446.","DOI":"10.1101\/2024.09.10.24313446"},{"key":"1321_CR40","volume-title":"StatPearls [Internet]","author":"C Foth","year":"2024","unstructured":"Foth, C., Gangwani, M. K., Ahmed, I. & Alvey, H. Ventricular tachycardia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; (2024)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01321-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01321-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01321-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:15:47Z","timestamp":1748996147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01321-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1321"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01321-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.10.24313446","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19542"}}